The text emphasizes the importance of reporting adverse drug events (ADEs), which are harmful occurrences linked to medication use. Such reporting is crucial for enhancing patient safety and refining drug monitoring systems. Healthcare professionals, patients, and caregivers can submit reports to regulatory agencies, providing essential information for evaluating drug safety. The collected data aids in identifying risks, informing clinical practices, and guiding regulatory decisions regarding drug approvals and warnings. Improved reporting mechanisms and heightened awareness are vital for reducing the incidence of ADEs and achieving better healthcare outcomes, alongside a focus on environmental health.